Related Experiment Videos
Polymorphonuclear leukocyte integrins in deep venous thrombosis
1Department of Internal Medicine, Cardiovascular and Renal Diseases, Università di Palermo, Palermo, Italy.
Summary
Polymorphonuclear leukocytes (PMN) in deep venous thrombosis (DVT) show altered CD11b and CD11c integrin expression. DVT patients exhibit impaired PMN activation responses, suggesting therapeutic targets for preventing vein damage.
Area of Science:
- Hematology
- Immunology
- Vascular Biology
Background:
- Polymorphonuclear leukocytes (PMN) play a role in deep venous thrombosis (DVT) pathophysiology.
- Beta(2)-integrins on PMNs are crucial for leukocyte adhesion and migration.
Purpose of the Study:
- To investigate the phenotypical expression of PMN beta(2)-integrins (CD11a, CD11b, CD11c) in individuals with leg DVT.
- To compare integrin expression and activation responses in DVT patients versus healthy controls.
Main Methods:
- Flow cytofluorimetry was used to analyze PMN beta(2)-integrin expression (CD11a, CD11b, CD11c) in 19 DVT subjects.
- PMN cells were evaluated at baseline and after in vitro activation with PMA and fMLP.
Main Results:
- DVT subjects showed decreased CD11b and increased CD11c expression at baseline compared to controls.
- In normal subjects, PMA and fMLP increased all PMN adhesion molecules.
- In DVT subjects, CD11a expression remained unchanged after activation, unlike in controls.
Conclusions:
- Altered PMN integrin expression and impaired activation in DVT patients may contribute to disease pathophysiology.
- These findings suggest potential therapeutic strategies targeting PMN integrins to prevent post-thrombotic vein dysfunction.